J Korean Ophthalmol Soc.  2004 Jun;45(6):1030-1035.

Management with Radical Excision in Squamous Cell Carcinoma of the Lacrimal Sac

Affiliations
  • 1Department of Ophthalmology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea. feeloph@hanmir.com

Abstract

PURPOSE
Squamous cell carcinoma of the lacrimal sac is rare and there is high rate of recurrence after dacryocystectomy. We report successful radical excision of the tumor for the purpose of reducing the recurrence and improving the survival rate. METHODS: A 48-year-old man who had a history of epiphora and medial canthal mass for one year was referred to our clinic. CT scan showed a mass on the lacrimal fossa but there was no evidence of bony destruction or local invasion. We confirmed that the excised mass was squamous cell carcinoma of the lacrimal sac by frozen section. So, radical excision including bony and mucous nasolacrimal duct (NLD), inferior turbinate, and medial maxilla was performed through lateral rhinotomy. RESULTS: Ten months later, there was skin defect and medial canthal deformity. So we corrected the deformity with a forehead free flap and the result was cosmetically acceptable. There was no evidence of recurrence or distant metastasis for one- year follow- up period. CONCLUSIONS: Despite its high recurrence rate, we can reduce the recurrence and mortality rate of squamous cell carcinoma of the lacrimal sac with radical excision including bony and mucous NLD, inferior turbinate, and medial maxilla.

Keyword

Lacrimal sac tumor; Radical excision; Squamous cell carcinoma

MeSH Terms

Carcinoma, Squamous Cell*
Congenital Abnormalities
Forehead
Free Tissue Flaps
Frozen Sections
Humans
Lacrimal Apparatus Diseases
Maxilla
Middle Aged
Mortality
Nasolacrimal Duct
Neoplasm Metastasis
Recurrence
Skin
Survival Rate
Tomography, X-Ray Computed
Turbinates
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr